Trump Demands Lower Drug Prices and Faster US Plant Approvals

Sunita Somvanshi

White House drops two pharmaceutical bombshells in May 2025 that could reshape the entire $500 billion industry.

Photo Source: Pixabay (Pexels)

Trump's May 5th executive order promises to slash drug plant approval times from 5-10 years to just months.

Photo Source: NVinacco (CC BY-NC-ND 2.0)

FDA, EPA, and Army Corps of Engineers get 180 days to streamline approval processes - or face presidential pressure.

Photo Source: Polina Tankilevitch (Pexels)

Foreign drug plants hit with higher inspection fees while US manufacturing gets fast-track treatment.

Photo Source: Chemist 4 U (CC BY 2.0)

PhRMA president Stephen Ubl warns: "Importing foreign prices from socialist countries would be a bad deal for American patients and workers.

Photo Source: Kaboompics.com (Pexels)

May 12th ultimatum gives drug companies just 30 days to voluntarily cut prices - or face government action

Photo Source: Pxhere

We're going to equalize," Trump declares. "We're all going to pay the same. We're going to pay what Europe pays.

Photo Source: Pixabay (Pexels)

Merck stock jumps 3.9% to $64.2 billion, Pfizer rises 2.5% to $63.6 billion - investors aren't panicking yet.

Photo Source: AlphaTradeZone (Pexels)

Biotech Innovation Organization president calls plan "deeply flawed" - warns it would "devastate small biotech companies.

Photo Source: ThisIsEngineering (Pexels)

Health expert Rachel Sachs reveals the timeline: "Years in the future" before prices actually drop.

Photo Source: Etatics Inc (Pexels)

RFK Jr., Dr. Oz, and Dr. Makary lead implementation - but courts blocked similar attempts in 2020.

Photo Source: Lance Reis (Pexels)

Senate Majority Leader Thune calls price controls "fairly controversial" if Congress gets involved.

Photo Source: Chemist 4 U (CC BY 2.0)